{
  "name": "Insilico Medicine",
  "slug": "insilico-medicine",
  "ticker": null,
  "fetched_at": "2026-01-21T12:29:18.628941+00:00",
  "news": [
    {
      "title": "Insilico agrees $66M deal to split rights for NLRP3 inhibitor - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaGRpZVdLSnBhOFNwZjFBajdudmowRUl4ME1hN0RQd0YxemJDamh0NHIzUmF6bC1BUWZadEN0QndqdVVTOGxfVnl4Yi1pby1rcy1Pb3NuSnlFZURHX1ZOM1F6c0VsZDR3alJHWUxlTUdYaFVYX1ZWck1nNHBhSUlBYXRIX1NaX1dxQWxwODBVZTdONjJxejI1U18wZUpFUXB4SnlwYVoxQ3NqVENzUjdmZTBScFZMQnZYTTRMNGN0RlM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQaGRpZVdLSnBhOFNwZjFBajdudmowRUl4ME1hN0RQd0YxemJDamh0NHIzUmF6bC1BUWZadEN0QndqdVVTOGxfVnl4Yi1pby1rcy1Pb3NuSnlFZURHX1ZOM1F6c0VsZDR3alJHWUxlTUdYaFVYX1ZWck1nNHBhSUlBYXRIX1NaX1dxQWxwODBVZTdONjJxejI1U18wZUpFUXB4SnlwYVoxQ3NqVENzUjdmZTBScFZMQnZYTTRMNGN0RlM?oc=5\" target=\"_blank\">Insilico agrees $66M deal to split rights for NLRP3 inhibitor</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-21T12:05:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "AI in Drug Discovery Market Research Report 2026-2040: NVIDIA, Insilico Medicine, Google DeepMind, Pfizer, and Roche Leveraging AI Platforms to Accelerate Development Timelines and Reduce R&D Costs - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQWjBRYkZDVnNMaHlZdi1mNkV1bWdyYWRnckFEQzFldTcybV92SVVuMkdfdWk0eFg2LVdWbXZQd2RRWFVSM2w5T1BLMERlUHhWZGdrRkhSenI3VWNCT182amREb2ZyLUN5NTR3enFucG50VnU0THkwUlJwNVJmYTFPM2RadUlUZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxQWjBRYkZDVnNMaHlZdi1mNkV1bWdyYWRnckFEQzFldTcybV92SVVuMkdfdWk0eFg2LVdWbXZQd2RRWFVSM2w5T1BLMERlUHhWZGdrRkhSenI3VWNCT182amREb2ZyLUN5NTR3enFucG50VnU0THkwUlJwNVJmYTFPM2RadUlUZw?oc=5\" target=\"_blank\">AI in Drug Discovery Market Research Report 2026-2040: NVIDIA, Insilico Medicine, Google DeepMind, Pfizer, and Roche Leveraging AI Platforms to Accelerate Development Timelines and Reduce R&amp;D Costs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-19T09:02:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQajFnamY1U29KdlEzamc1MGtBbVVVUjB6TVdQeVpveVNWcGhMU1lDbWdHYVRIVC1wa0xXUkNpMGl4Wm8yOFVLSFVBY2dYQ2cwc0hnOWxqT0IyYWkzNTc4VE93UHFDQjZhcDdUMXpBb1cwUHRjTjlNT1ZlMDFQZHVnNEZ3UmZ0bFc0aWJnUkhNZTA4SW9KV0FFM1VxOW10T0NHdXQ3UzNzRG90ZTZ0aUxMbGN6cDJYM1U4WGlxYXZIV0xkYlRoN3J2OTVQMXE2S2pUdm1lZWpRRUdUclpuR2ZoSnZoOGhidGhvd0lYQkprUTdDbFlJel9DMzhTMGRIOWtLVndXemREamJfTWYtU1lzdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAJBVV95cUxQajFnamY1U29KdlEzamc1MGtBbVVVUjB6TVdQeVpveVNWcGhMU1lDbWdHYVRIVC1wa0xXUkNpMGl4Wm8yOFVLSFVBY2dYQ2cwc0hnOWxqT0IyYWkzNTc4VE93UHFDQjZhcDdUMXpBb1cwUHRjTjlNT1ZlMDFQZHVnNEZ3UmZ0bFc0aWJnUkhNZTA4SW9KV0FFM1VxOW10T0NHdXQ3UzNzRG90ZTZ0aUxMbGN6cDJYM1U4WGlxYXZIV0xkYlRoN3J2OTVQMXE2S2pUdm1lZWpRRUdUclpuR2ZoSnZoOGhidGhvd0lYQkprUTdDbFlJel9DMzhTMGRIOWtLVndXemREamJfTWYtU1lzdw?oc=5\" target=\"_blank\">Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-12-30T08:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Fosun Pharma-funded biotech licenses Insilico’s NLRP3 inhibitor - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZXBmeVRaZkxucFNrcTNMYjR4LTJGUUI0RHcxU0NROHBTVnFsQWdCcHpnUHBueDZVa3V3Z2IwTUo3RVptR3JCN09lRWVfV2hISWJ6NHVfRFpHUzE5aEpOcHF2LURLTEdMTFMwWHpwWXhtVi1pZFpDaGR1RS0xdGVVcWxMdHdZNGxqSWp4LVE3blpVNDhzZURIbTVhQjBsTDlvWG1iX05HZERIZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZXBmeVRaZkxucFNrcTNMYjR4LTJGUUI0RHcxU0NROHBTVnFsQWdCcHpnUHBueDZVa3V3Z2IwTUo3RVptR3JCN09lRWVfV2hISWJ6NHVfRFpHUzE5aEpOcHF2LURLTEdMTFMwWHpwWXhtVi1pZFpDaGR1RS0xdGVVcWxMdHdZNGxqSWp4LVE3blpVNDhzZURIbTVhQjBsTDlvWG1iX05HZERIZw?oc=5\" target=\"_blank\">Fosun Pharma-funded biotech licenses Insilico’s NLRP3 inhibitor</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2026-01-21T12:14:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases Treatment - citybiz",
      "link": "https://news.google.com/rss/articles/CBMipwJBVV95cUxOYjJ3VHpMbnhnWDViRi1yWlY3OFV6TGxNLTZycF96QmlLZnpCdzYtc2dTZUpTTHpxSjBvdmJoQXVtOXhFNHlZSU5kV1o2M1Z1VUltX0ZqanFsUE9xT0tDX1JxeXZ3MDdneGNWUGZ5OXlHaWJyLUtha3FqVW5vZ21RX3RCWE95a0FOQ19BZUc2Tld4YW5qMGNMUHBQRnREcEk0UVdwdGZKU2NDNmNtaWVoZXBxekFoZU1GYXN3OTZfYnNKV2pXallpbllyWTM0SkJxWlYwclRJekszdGJVZjEzaDYwNW1rT0xiN2lfLUlBel85VjNlSjFEWFdESVFRNmp0U1Z0UWpHWkdYNHQxRWloOFZEbUlnWFFxdkxJWW1pQUIzTUFqdnpR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwJBVV95cUxOYjJ3VHpMbnhnWDViRi1yWlY3OFV6TGxNLTZycF96QmlLZnpCdzYtc2dTZUpTTHpxSjBvdmJoQXVtOXhFNHlZSU5kV1o2M1Z1VUltX0ZqanFsUE9xT0tDX1JxeXZ3MDdneGNWUGZ5OXlHaWJyLUtha3FqVW5vZ21RX3RCWE95a0FOQ19BZUc2Tld4YW5qMGNMUHBQRnREcEk0UVdwdGZKU2NDNmNtaWVoZXBxekFoZU1GYXN3OTZfYnNKV2pXallpbllyWTM0SkJxWlYwclRJekszdGJVZjEzaDYwNW1rT0xiN2lfLUlBel85VjNlSjFEWFdESVFRNmp0U1Z0UWpHWkdYNHQxRWloOFZEbUlnWFFxdkxJWW1pQUIzTUFqdnpR?oc=5\" target=\"_blank\">Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases Treatment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">citybiz</font>",
      "published": "2026-01-20T16:38:45+00:00",
      "source": "citybiz"
    },
    {
      "title": "Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases Treatment - marketscreener.com",
      "link": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNMmE0aURGOE93NFIyLXJkS003clh2U3ZjSFg1YmxPUGRLQmRpUmJpdWNqaHRHMWNEeldXdjdGNDRVSjZPdmxlLV9DSnVJZnpZWTY0SHFHaDJ3MEZwTm9XLUNHNkdycUMySnViTmJWYk5IaW1NWTRNc0lzYzNEMnlzMGxSX25jNjVBdE1kS3VHZExKUFNYeHpOLTJ2RXpRS3l4M2xLcXpMd0VoRk1XX0x3TjdfaFVlN3liZ3N2bEdhUXVyV3JyTTc4Sy1NYlpCaF8wU3hYQVEtTkZ1Sy1fdUF2TjhuakVZMERm?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNMmE0aURGOE93NFIyLXJkS003clh2U3ZjSFg1YmxPUGRLQmRpUmJpdWNqaHRHMWNEeldXdjdGNDRVSjZPdmxlLV9DSnVJZnpZWTY0SHFHaDJ3MEZwTm9XLUNHNkdycUMySnViTmJWYk5IaW1NWTRNc0lzYzNEMnlzMGxSX25jNjVBdE1kS3VHZExKUFNYeHpOLTJ2RXpRS3l4M2xLcXpMd0VoRk1XX0x3TjdfaFVlN3liZ3N2bEdhUXVyV3JyTTc4Sy1NYlpCaF8wU3hYQVEtTkZ1Sy1fdUF2TjhuakVZMERm?oc=5\" target=\"_blank\">Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases Treatment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>",
      "published": "2026-01-21T06:51:09+00:00",
      "source": "marketscreener.com"
    },
    {
      "title": "Insilico Medicine Strikes HK$500 Million Global Pact with Hygtia for Brain-Penetrant NLRP3 Inhibitor - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNajN1WVZESlMtcUF0YWszUVlwQmV1U1U4NG9LMzdFcEpBazJEOUYySFlHdlhaMWEwU1h1TTl3Ym9vR3VlSkIxa2NuR1ZxZThldlVuekRIYnVkQVEzQlBucVJSdTJLNFJER1QyRjFST1RLUnpFV0ZYTHl4a01RM0REODdtMUNud0dCcG1NWHUySjJWV1E2YW40a2xwX3ZoQkIyR0VEWFdCdWJaandoWjBrc1o5S2dsWmVqWVluLXgyQlVMWHVIZHZqOHBVNWpLeXhuUDhVMDdTVHpOR1JzdXB3X0otNk5xdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNajN1WVZESlMtcUF0YWszUVlwQmV1U1U4NG9LMzdFcEpBazJEOUYySFlHdlhaMWEwU1h1TTl3Ym9vR3VlSkIxa2NuR1ZxZThldlVuekRIYnVkQVEzQlBucVJSdTJLNFJER1QyRjFST1RLUnpFV0ZYTHl4a01RM0REODdtMUNud0dCcG1NWHUySjJWV1E2YW40a2xwX3ZoQkIyR0VEWFdCdWJaandoWjBrc1o5S2dsWmVqWVluLXgyQlVMWHVIZHZqOHBVNWpLeXhuUDhVMDdTVHpOR1JzdXB3X0otNk5xdw?oc=5\" target=\"_blank\">Insilico Medicine Strikes HK$500 Million Global Pact with Hygtia for Brain-Penetrant NLRP3 Inhibitor</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-01-20T00:11:57+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Insilico ends 2025 with $293m Hong Kong IPO - pharmaphorum",
      "link": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1pZmxkbzJiRUhBMEVWYnNGWHpjZmd4MFlqSnNRV2J3ZmFheHBLbE9lYVhDYUQyN3lHS3BWRVZ5VU1aLVJZSEdLbi1WNFh4c0R4aDRGRDNsejdkZWFFLUdYbnVlN2ZXcktzSnhTczV4Uk5oWEtpQ3c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMidkFVX3lxTE1pZmxkbzJiRUhBMEVWYnNGWHpjZmd4MFlqSnNRV2J3ZmFheHBLbE9lYVhDYUQyN3lHS3BWRVZ5VU1aLVJZSEdLbi1WNFh4c0R4aDRGRDNsejdkZWFFLUdYbnVlN2ZXcktzSnhTczV4Uk5oWEtpQ3c?oc=5\" target=\"_blank\">Insilico ends 2025 with $293m Hong Kong IPO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">pharmaphorum</font>",
      "published": "2025-12-31T08:00:00+00:00",
      "source": "pharmaphorum"
    }
  ],
  "product_launches": [
    {
      "title": "Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence - EurekAlert!",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1fQ3JoeTNfM0xQN3ZpX3hhcS1DTWY5U0RnQ2dtM3c0QnZOM1p1M01JcnFwVkRqejlrc1Q4QnVtblM1Rl9QeVZEZ004YnlFZXZ3eGtMVjIxN2haUnE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1fQ3JoeTNfM0xQN3ZpX3hhcS1DTWY5U0RnQ2dtM3c0QnZOM1p1M01JcnFwVkRqejlrc1Q4QnVtblM1Rl9QeVZEZ004YnlFZXZ3eGtMVjIxN2haUnE0?oc=5\" target=\"_blank\">Insilico Medicine’s Pharma.AI Q4 Winter Launch Recap: Revolutionizing drug discovery with cutting-edge AI innovations, accelerating the path to pharmaceutical superintelligence</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">EurekAlert!</font>",
      "published": "2025-12-19T08:00:00+00:00",
      "source": "EurekAlert!"
    },
    {
      "title": "Insilico Pharma.AI fall launch recap: Understand latest AI updates for healthcare research with frequent questions answered - EurekAlert!",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE53VHVHSXcwdU1qUUhyVU1KUzVyMnkxbGxCRnVLT09yYnA5VE5pRWQ1emFNdnVVd1hoS09mQ0VDa3dOYWVfLVVJOGJ1OFRmcEMteTFYOXFIUkZlQVgt?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE53VHVHSXcwdU1qUUhyVU1KUzVyMnkxbGxCRnVLT09yYnA5VE5pRWQ1emFNdnVVd1hoS09mQ0VDa3dOYWVfLVVJOGJ1OFRmcEMteTFYOXFIUkZlQVgt?oc=5\" target=\"_blank\">Insilico Pharma.AI fall launch recap: Understand latest AI updates for healthcare research with frequent questions answered</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">EurekAlert!</font>",
      "published": "2025-10-21T07:00:00+00:00",
      "source": "EurekAlert!"
    },
    {
      "title": "Novo Nordisk Launches First GLP-1 Pill for Obesity in U.S. on January 5, 2026 - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPUUtfVE9kYjI2UjFIeDJlcms0Vm5HRE5naVVYTW52MWVXTldsWkpocnprTHVxZnE0MUY4MU94aEloWUtLczZlQjhDaFVzcGhGZGF6Tzlod09wbmc2U01id2hXdlNaNkhLako3dkhLR1JkUDN3VVNNMUJmNWZpX2R0NHJrMG1mZzJ5Z3BTR1Z3cnlTZXpDQ3lvNURGVXN6aklNLVByTk9B?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPUUtfVE9kYjI2UjFIeDJlcms0Vm5HRE5naVVYTW52MWVXTldsWkpocnprTHVxZnE0MUY4MU94aEloWUtLczZlQjhDaFVzcGhGZGF6Tzlod09wbmc2U01id2hXdlNaNkhLako3dkhLR1JkUDN3VVNNMUJmNWZpX2R0NHJrMG1mZzJ5Z3BTR1Z3cnlTZXpDQ3lvNURGVXN6aklNLVByTk9B?oc=5\" target=\"_blank\">Novo Nordisk Launches First GLP-1 Pill for Obesity in U.S. on January 5, 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2026-01-05T17:37:05+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZUVqZmt1UEV2cWJRbUlZZkduYmVOaGVpWnNfeldmcHJiM1YweTJxR3BOT1l0V2xNY2ZjVlNteGgwMmNXSlJEM2E4ZElnbS1rbDVRUmtmMm1SRFh2WVlKTGtuWE5LREhFa3FPM3RybHh2LVlZNEVIN2JmcnNnUjNqTm1QSFMyQVVqUFBHTXZyX1d2MFd3WXVFQm05M1J0ai03WGZmYmplWldjdTlGUjN1elhkSUxwZ2xYZzN3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZUVqZmt1UEV2cWJRbUlZZkduYmVOaGVpWnNfeldmcHJiM1YweTJxR3BOT1l0V2xNY2ZjVlNteGgwMmNXSlJEM2E4ZElnbS1rbDVRUmtmMm1SRFh2WVlKTGtuWE5LREhFa3FPM3RybHh2LVlZNEVIN2JmcnNnUjNqTm1QSFMyQVVqUFBHTXZyX1d2MFd3WXVFQm05M1J0ai03WGZmYmplWldjdTlGUjN1elhkSUxwZ2xYZzN3?oc=5\" target=\"_blank\">AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2024-07-24T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "North America AI in Pharma & Biotech Market Size, Share [2032] - Fortune Business Insights",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxONGh0ZUxRT3RUalR1LXl3ejlwc0FLWnNDZ3hsTEFhLU5Qa3l3VnB6Q1NheVRWN0pNZ0doS25GQUNyUTJfaEtEcmpsa0xIRlhuTGJNZmtJVFRycmVCQXVyT1ZWTXNXeFBqVUJ4c2l1TDhQV0tyTG5LRE5hRXh2MEhiTFRSaExPWG9WZWFpM0RSa2RTUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxONGh0ZUxRT3RUalR1LXl3ejlwc0FLWnNDZ3hsTEFhLU5Qa3l3VnB6Q1NheVRWN0pNZ0doS25GQUNyUTJfaEtEcmpsa0xIRlhuTGJNZmtJVFRycmVCQXVyT1ZWTXNXeFBqVUJ4c2l1TDhQV0tyTG5LRE5hRXh2MEhiTFRSaExPWG9WZWFpM0RSa2RTUQ?oc=5\" target=\"_blank\">North America AI in Pharma & Biotech Market Size, Share [2032]</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fortune Business Insights</font>",
      "published": "2025-04-16T12:06:30+00:00",
      "source": "Fortune Business Insights"
    }
  ],
  "stock": null
}